Dialysetherapie und Nierentransplantation

Schlüsselwörter

chronisches Nierenversagen - Dialyse - Peritonealdialyse - Nierentransplantation

Keywords

chronic renal failure - dialysis - peritoneal dialysis - renal transplantation

Literatur

• 1 Budde K. et al, ZEUS Study Investigators . Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants.  Lancet. 2011;  377 837-847
• 2 Cooper B A, Branley P, Bulfone L. et al, IDEAL Study . A randomized, controlled trail of early versus late initiation of dialysis.  N Engl J Med. 2010;  363 609-619
• 3 Covic A, Bammens B, Lobbedez T. et al . Educating end-stage renal disease patients on dialysis modality selection: a clinical advice from the European Renal Best Practice (ERBP) Advisory Board.  NDT Plus. 2010;  3 225-233
• 4 Culleton B F, Walsh M, Klarenbach S W. et al . Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life.  JAMA. 2007;  298 1291-1299
• 5 Durrbach A, Pestana J M, Pearson T. et al . A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study).  Am J Transplant. 2010;  10 547-557
• 6 Ekberg H, Tedesco-Silva H, Demirbas A. et al, for the ELITE-Symphony Study . Reduced exposure to calcineurin inhibitors in renal transplantation.  N Engl J Med. 2007;  357 2562-2575
• 7 Hanaway M J, Woodle E S, Mulgaonkar S. et al, INTAC Study Group . Alemtuzumab induction in renal transplantation.  N Engl J Med. 2011;  364 1909-1919
• 8 Jefferies H J, Virk B, Schiller B, Moran J, McIntyre C W. Frequent hemodialysis schedules are associated with reduced levels of dialysis-induced cardiac injury (myocardial stunning).  Clin J Am Soc Nephrol. 2011;  6 1326-1332
• 9 Kainz A, Wilflingseder J, Mitterbauer C. et al . Steroid pretreatment of organ donors to prevent postischemic renal allograft failure.  Ann Intern Med. 2010;  153 222-230
• 10 Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group . KDIGO clinical practice guideline for the care of kidney transplant recipients.  Am J Transplant. 2009;  9 (Suppl 3) S1-157
• 11 Kooienga L. Phosphorus balance with daily dialysis.  Semin Dial. 2007;  20 342-345
• 12 Lebranchu Y, Thierry A, Toupance O. et al . Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept study.  Am J Transplant. 2009;  9 1115-1123
• 13 Marenzi G, Lauri G, Grazi M. et al . Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure.  J Am Coll Cardiol. 2001;  38 963
• 14 Rosansky S, Glassock R J, Clark W F. Early start of dialysis.  J Am Soc Nephrol. 2011;  6 1222-1228
• 15 Schnuelle P, Gottmann U, Hoeger S. et al . Effects of donor pretreatment with dopamine on graft function after kidney transplantation.  JAMA. 2009;  302 1067-1075
• 16 Stock P G, Barin B, Murphy B. et al . Outcomes of kidney transplantation in HIV-infected recipients.  N Engl J Med. 2010;  363 2004-2014
• 17 Unruh M. Sleep apnoea and dialysis therapies: things that go bump in the night?.  Hemodial Int. 2007;  11 369-378
• 18 Vincenti F, Charpentier B, Vanrenterghem Y. et al . A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).  Am J Transplant. 2010;  10 535-546
• 19 Weir M R, Mulgaonkar S, Chan L. et al . Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation.  Kidney Int. 2011;  79 897-907